Biotechnology
Inovio Pharmaceuticals held its first-quarter 2026 earnings call on May 13 to discuss financial results for the period ended March 31 and provide updates on its DNA medicines platform.
An Ruwaito ta hanyar AI
Pulse Biosciences outlined its progress with nanosecond pulsed field ablation technology during a presentation at the Bank of America Global Healthcare Conference on May 13.
Researchers from the University of Barcelona and the University of Oregon report that short DNA molecules known as polypurine reverse Hoogsteen hairpins (PPRHs) suppressed the PCSK9 gene and reduced blood cholesterol in a mouse model. In transgenic mice carrying the human PCSK9 gene, a single injection of one candidate (HpE12) cut plasma PCSK9 by 50% and total cholesterol by 47% three days later, according to findings published in Biochemical Pharmacology.
An Ruwaito ta hanyar AI
Illumina Inc. conducted its first-quarter 2026 earnings conference call on April 30, 2026, at 4:30 PM EDT. CEO Jacob Thaysen and CFO Ankur Dhingra presented updates on the business and financial results. The company released its earnings after market close, available on its investor relations website.
Engineered E. coli produces natural sunscreen compound gadusol
May 12, 2026 16:47Engineered algae removes microplastics from water
May 12, 2026 13:13Verrica pharmaceuticals holds q1 2026 earnings call
May 12, 2026 11:26Intellia reports strong phase iii results for hae treatment
May 09, 2026 16:44Study identifies SP6 and SP8 as shared regeneration genes in axolotls, zebrafish and mice
April 30, 2026 12:13Scientists restore memory in Alzheimer's mice by blocking PTP1B
April 30, 2026 05:54Syntara reports positive FDA feedback on amsulostat trial
April 28, 2026 06:24University of Utah researchers identify enzyme PapB that can “lock” GLP-1-like peptides into ring structures
April 25, 2026 15:49Scientists uncover PEX11 protein's role in controlling plant peroxisome size
April 22, 2026 00:13Chilean scientists develop ulmo honey patch for wounds